Side-by-side comparison of AI visibility scores, market position, and capabilities
Wealth and asset management with $17.1B FY2024 revenue; 10,000 advisors; Columbia Threadneedle $700B+ AUM; CEO Jim Cracchiolo 20-year tenure; 80%+ earnings returned to shareholders.
Ameriprise Financial is a leading wealth management and asset management company, founded in 1894 as Investors Syndicate within American Express and spun off as an independent public company in 2005, headquartered in Minneapolis, Minnesota and trading on NYSE (AMP). For FY2024, Ameriprise generated approximately $17.1 billion in total revenues under CEO Jim Cracchiolo, who has led the company since its 2005 IPO and transformed it from a diversified financial services company into a focused wealth and asset management powerhouse. The company serves approximately 2 million individual, business, and institutional clients through its network of approximately 10,000 financial advisors and through Columbia Threadneedle Investments, its global asset management subsidiary managing over $700 billion in assets.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.